XML 52 R34.htm IDEA: XBRL DOCUMENT
v3.21.2

Summary of Significant Accounting Policies (Tables) | 5 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Dec. 31, 2020 | Sep. 30, 2021 | Dec. 31, 2020
Summary of Significant Accounting Policies (Tables) [Line Items] |  |  |
Schedule of basic and diluted net loss per share for each class of common stock |
|  | For the period from August 11, 2020 (inception) through December 31, 2020
|  | Class A |  | Class B
Basic and diluted net loss per common share: |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |
Allocation of net loss |  | $ | (2,841,640 | ) |  | $ | (1,381,893 | )
Denominator: |  |  |  |  |  |  |  |
Basic and diluted weighted average common shares outstanding |  |  | 5,911,972 |  |  |  | 2,875,000 |
Basic and diluted net loss per common share |  | $ | (0.48 | ) |  | $ | (0.48 | )
|  | For the Three Months Ended September 30, 2021 |  | For the Nine Months Ended September 30, 2021 |  | For the Period from August 11 (Inception) to September 30, 2020
|  | Class A |  | Class B |  | Class A |  | Class B |  | Class B
Basic and diluted net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of net income (loss) |  | $ | 479,385 |  | $ | 65,102 |  | $ | (420,345 | ) |  | $ | (87,867 | ) |  | $ | (2,065 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic and diluted weighted average common shares outstanding |  |  | 27,600,000 |  |  | 3,066,666 |  |  | 26,184,615 |  |  |  | 3,046,153 |  |  |  |  |
Basic and diluted net income (loss) per common share |  | $ | 0.04 |  | $ | 0.04 |  | $ | (0.04 | ) |  | $ | (0.04 | ) |  | $ | — |
Schedule of balance sheet |  |
|  | As Previously Reported |  | Adjustments |  | As Restated
Balance sheet as of March 31, 2021 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Total assets |  | $ | 115,725,964 |  |  |  | — |  |  | $ | 115,725,964 |
Total liabilities |  | $ | 10,894,008 |  |  |  | — |  |  | $ | 10,894,008 |
Class A common stock subject to possible redemption |  |  | 99,831,950 |  |  |  | 15,168,050 |  |  |  | 115,000,000 |
Preferred stock |  |  | — |  |  |  | — |  |  |  | — |
Class A common stock |  |  | 152 |  |  |  | (152 | ) |  |  | — |
Class B common stock |  |  | 288 |  |  |  | — |  |  |  | 288 |
Additional paid-in capital |  |  | 7,233,231 |  |  |  | (7,233,231 | ) |  |  | — |
Accumulated deficit |  |  | (2,233,665 | ) |  |  | (7,934,667 | ) |  |  | (10,168,332 | )
Total stockholders’ equity (deficit) |  | $ | 5,000,006 |  |  | $ | (15,168,050 | ) |  | $ | (10,168,044 | )
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) |  | $ | 115,725,964 |  |  | $ | — |  |  | $ | 115,725,964 |
|  | As Previously Reported |  | Adjustments |  | As Restated
Balance sheet as of June 30, 2021 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Total assets |  | $ | 115,464,516 |  |  |  | — |  |  | $ | 115,464,516 |
Total liabilities |  | $ | 13,675,127 |  |  |  | — |  |  | $ | 13,675,127 |
Class A common stock subject to possible redemption |  |  | 96,789,380 |  |  |  | 18,210,620 |  |  |  | 115,000,000 |
Preferred stock |  |  | — |  |  |  | — |  |  |  | — |
Class A common stock |  |  | 182 |  |  |  | (182 | ) |  |  | — |
Class B common stock |  |  | 288 |  |  |  | — |  |  |  | 288 |
Additional paid-in capital |  |  | 10,275,771 |  |  |  | (10,275,771 | ) |  |  | — |
Accumulated deficit |  |  | (5,276,232 | ) |  |  | (7,934,667 | ) |  |  | (13,210,899 | )
Total stockholders’ equity (deficit) |  | $ | 5,000,009 |  |  | $ | (18,210,620 | ) |  | $ | (13,210,611 | )
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) |  | $ | 115,464,516 |  |  | $ | — |  |  | $ | 115,464,516 |
Schedule of supplemental disclosure of noncash financing activities |  |
|  | As Previously Reported |  | Adjustments |  | As Restated
Supplemental Disclosure of Noncash Financing Activities: |  |  |  |  |  |  |  |  |  |
Change in value of Class A common stock subject to possible redemption |  | $ | 1,989,870 |  | $ | (1,989,870 | ) |  | $ | —
|  | As Previously Reported |  | Adjustments |  | As Restated
Supplemental Disclosure of Noncash Financing Activities: |  |  |  |  |  |  |  |  |  |
Change in value of Class A common stock subject to possible redemption |  | $ | (1,052,700 | ) |  | $ | 1,052,700 |  | $ | —
Schedule of weighted average shares outstanding and basic and diluted net income (loss) per common share |  |
|  | Net Income Per Share
|  | As Reported |  | Adjustment |  | As Restated
Three Months Ended March 31, 2021 (Unaudited) |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 1,989,868 |  | $ | — |  |  | $ | 1,989,868
Weighted average shares outstanding – Class A common stock |  |  | 11,500,000 |  |  | — |  |  |  | 11,500,000
Basic and diluted net income per share – Class A common stock |  | $ | 0.00 |  | $ | 0.14 |  |  | $ | 0.14
Weighted average shares outstanding – Class B common stock |  |  | 2,875,000 |  |  | — |  |  |  | 2,875,000
Basic and diluted net income per share – Class B common stock |  | $ | 0.69 |  | $ | (0.55 | ) |  | $ | 0.14
|  | Net Loss Per Share
|  | As Reported |  | Adjustment |  | As Restated
Three Months Ended June 30, 2021 (Unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (3,042,567 | ) |  | $ | — |  |  | $ | (3,042,567 | )
Weighted average shares outstanding – Class A common stock |  |  | 11,500,000 |  |  |  | — |  |  |  | 11,500,000 |
Basic and diluted net loss per share – Class A common stock |  | $ | 0.00 |  |  | $ | (0.21 | ) |  | $ | (0.21 | )
Weighted average shares outstanding – Class B common stock |  |  | 2,875,000 |  |  |  | — |  |  |  | 2,875,000 |
Basic and diluted net loss per share – Class B common stock |  | $ | (1.06 | ) |  | $ | 0.85 |  |  | $ | (0.21 | )
|  | Net Loss Per Share
|  | As Reported |  | Adjustment |  | As Restated
Six Months Ended June 30, 2021 (Unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (1,052,699 | ) |  | $ | — |  |  | $ | (1,052,699 | )
Weighted average shares outstanding – Class A common stock |  |  | 11,500,000 |  |  |  | — |  |  |  | 11,500,000 |
Basic and diluted net loss per share – Class A common stock |  | $ | 0.00 |  |  | $ | (0.07 | ) |  | $ | (0.07 | )
Weighted average shares outstanding – Class B common stock |  |  | 2,875,000 |  |  |  | — |  |  |  | 2,875,000 |
Basic and diluted net loss per share – Class B common stock |  | $ | (0.37 | ) |  | $ | 0.30 |  |  | $ | (0.07 | )
Ambulnz, Inc. [Member] |  |  |
Summary of Significant Accounting Policies (Tables) [Line Items] |  |  |
Summary of estimated useful live |  |
Asset Category |  | Estimated Useful Lives
Buildings |  | 39 years
Office equipment and furniture |  | 3 years
Vehicles |  | 5-8 years
Medical equipment |  | 5 years
Leasehold improvements |  | Shorter of useful life of asset or lease term
Asset Category |  | Estimated Useful Lives
Buildings |  | 39 years
Office equipment and furniture |  | 3 years
Vehicles |  | 5 – 8 years
Medical equipment |  | 5 years
Leasehold improvements |  | Shorter of useful life of asset or lease term
Schedule of revenue disaggregated |  |
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Primary Geographical Markets |  |  |  |  |  |  |  |  |  |  |  |
United States |  | $ | 83,286,509 |  | $ | 25,345,926 |  | $ | 190,595,217 |  | $ | 58,916,146
United Kingdom |  |  | 2,552,479 |  |  | 1,590,687 |  |  | 6,799,162 |  |  | 3,934,287
Total revenue |  | $ | 85,838,988 |  | $ | 26,936,613 |  | $ | 197,394,379 |  | $ | 62,850,433
Major Segments/Service Lines |  |  |  |  |  |  |  |  |  |  |  |
Core Transportation Services |  | $ | 17,916,162 |  | $ | 15,242,251 |  | $ | 65,657,141 |  | $ | 47,577,542
Mobile Health |  |  | 67,922,826 |  |  | 11,694,362 |  |  | 131,737,238 |  |  | 15,272,891
Total revenue |  | $ | 85,838,988 |  | $ | 26,936,613 |  | $ | 197,394,379 |  | $ | 62,850,433
|  | For the Years Ended December 31,
2020 |  | 2019
Primary Geographical Markets |  |  |  |  |  |
United States |  | $ | 88,362,445 |  | $ | 45,931,306
United Kingdom |  |  | 5,728,213 |  |  | 2,367,806
Total revenue |  | $ | 94,090,658 |  | $ | 48,299,112
Major Segments/Service Lines |  |  |  |  |  |
Transportation Services |  | $ | 63,188,855 |  | $ | 46,424,896
Mobile Health |  |  | 30,901,803 |  |  | 1,874,216
Total revenue |  | $ | 94,090,658 |  | $ | 48,299,112

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References No definition available. + Details
Name: | dcgo_DisaggregationOfRevenuesTableTextBlock
Namespace Prefix: | dcgo_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | dcgo_SummaryofSignificantAccountingPoliciesTablesLineItems
Namespace Prefix: | dcgo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 980 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=84167750&loc=d3e42232-110370 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13(b)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=dcgo_AmbulnzIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |